Majeed Tazeen, Hopkin Gareth, Wang Katie, Nepal Smriti, Votruba Nicole, Gronholm Petra, Gurung Dristy, Semrau Maya, Bagade Tanmay, Farina Nick, Musyimi Christine, Pingani Luca, Breuer Erica, Lund Crick, Thornicroft Graham, Evans-Lacko Sara
School of Medicine and Public Health, College of Health, Medicine and Wellbeing, University of Newcastle, Australia.
National Institute for Health and Care Excellence, United Kingdom.
EClinicalMedicine. 2024 Apr 26;72:102612. doi: 10.1016/j.eclinm.2024.102612. eCollection 2024 Jun.
Stigma exacerbates power imbalances and societal disparities, significantly impacting diverse identities and health conditions, particularly for low and middle-income countries (LMICs). Though crucial for dismantling harmful stereotypes, and enhancing healthcare utilisation, existing research on anti-stigma interventions is limited with its condition-focused approach. We aimed to thoroughly evaluate peer-reviewed and non-peer-reviewed literature for a comprehensive review of anti-stigma interventions for diverse identities and all health conditions in LMICs.
This review systematically explored peer-reviewed and non-peer-reviewed literature, in ten electronic databases up to January 30, 2024, covering all anti-stigma interventions across various stigmatised identities and health conditions in LMICs. Quality assessment for this systematic review was conducted as per Cochrane Collaboration's suggested inclusions. The review was registered with PROSPERO (Registration: 2017 CRD42017064283).
Systematic synthesis of the 192 included studies highlights regional imbalances, while providing valuable insights on robustness and reliability of anti-stigma research. Most studies used quasi-experimental design, and most centred on HIV/AIDS or mental health related stigma, with very little work on other issues. Certain high-population LMICs had no/little representation.
The interventions targeted diverse segments of populations and consequently yielded a multitude of stigma-related outcomes. However, despite the heterogeneity of studies, most reported positive outcomes underscoring the effectiveness of existing interventions to reduce stigma.
This study is supported by the UK Medical Research Council Indigo Partnership (MR/R023697/1) award.
耻辱感加剧了权力失衡和社会不平等,对不同身份群体和健康状况产生重大影响,在低收入和中等收入国家(LMICs)尤为如此。尽管消除有害刻板印象和提高医疗保健利用率至关重要,但现有关于反耻辱干预措施的研究因其以疾病为重点的方法而受到限制。我们旨在全面评估同行评审和非同行评审文献,以全面综述LMICs中针对不同身份群体和所有健康状况的反耻辱干预措施。
本综述系统地检索了截至2024年1月30日的十个电子数据库中的同行评审和非同行评审文献,涵盖了LMICs中针对各种受耻辱身份群体和健康状况的所有反耻辱干预措施。根据Cochrane协作网建议的纳入标准对本系统综述进行质量评估。该综述已在PROSPERO注册(注册号:2017 CRD42017064283)。
对纳入的192项研究进行系统综合分析,突出了区域不平衡,同时为反耻辱研究的稳健性和可靠性提供了有价值的见解。大多数研究采用准实验设计,且大多数集中在与艾滋病毒/艾滋病或心理健康相关的耻辱感上,而针对其他问题的研究很少。某些人口众多的LMICs没有/很少有相关研究报道。
这些干预措施针对不同人群,因此产生了许多与耻辱感相关的结果。然而,尽管研究存在异质性,但大多数报告的积极结果强调了现有干预措施在减少耻辱感方面的有效性。
本研究由英国医学研究理事会靛蓝合作项目(MR/R023697/1)资助。